Correlation Between Clal Biotechnology and Inbar Group

Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Inbar Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Inbar Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clal Biotechnology Industries and Inbar Group Finance, you can compare the effects of market volatilities on Clal Biotechnology and Inbar Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Inbar Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Inbar Group.

Diversification Opportunities for Clal Biotechnology and Inbar Group

-0.67

Correlation Coefficient

Clal Biotechnology  Inbar Group

Excellent diversification

The 3 months correlation between Clal and Inbar is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Inbar Group Finance in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inbar Group Finance and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Inbar Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inbar Group Finance has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Inbar Group go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Inbar Group

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to under-perform the Inbar Group. But the stock apears to be less risky and, when comparing its historical volatility, Clal Biotechnology Industries is 1.81 times less risky than Inbar Group. The stock trades about -0.06 of its potential returns per unit of risk. The Inbar Group Finance is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  25,000  in Inbar Group Finance on August 31, 2024 and sell it today you would earn a total of  7,420  from holding Inbar Group Finance or generate 29.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	97.87%
Values	Daily Returns

Clal Biotechnology Industries  vs.  Inbar Group Finance

Clal Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Inbar Group Finance

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Inbar Group Finance are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Inbar Group sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Clal Biotechnology and Inbar Group

The main advantage of trading using opposite Clal Biotechnology and Inbar Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Inbar Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inbar Group will offset losses from the drop in Inbar Group's long position.

The idea behind Clal Biotechnology Industries and Inbar Group Finance pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.